首页 › 子宫内膜癌 › 密歇根州 › Grand Rapids
Grand Rapids MI 子宫内膜癌临床试验
18项针对 子宫内膜癌的研究正在 Grand Rapids及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
招募中3 期
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
- Trinity Health Grand Rapids Hospital, Grand Rapids
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
招募中2 期
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
- Trinity Health Grand Rapids Hospital, Grand Rapids
A Study of PHST001 in Advanced Solid Tumors
招募中1 期
- START Center for Cancer Research - Midwest, Grand Rapids
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
招募中1 期
- South Texas Accelerated Research Therapeutics (START), Grand Rapids
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
招募中1/2 期
- BAMF Health, Grand Rapids
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
招募中2 期
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
招募中2 期
- Research Site, Grand Rapids
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
招募中1 期
- BAMF Health Inc., Grand Rapids
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
招募中1/2 期
- START Midwest, Grand Rapids
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
招募中观察性研究
- Cancer & Hematology Centers of Western Michigan, Grand Rapids
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
招募中3 期
- Corewell Health, Grand Rapids
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
招募中1 期
- South Texas Accelerated Research Therapeutics (START) Midwest, Grand Rapids
A Study of MGC026 in Participants With Advanced Solid Tumors
招募中1 期
- START Midwest, Grand Rapids
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
招募中1 期
- START - Midwest, Grand Rapids
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
招募中1/2 期
- START Midwest, Grand Rapids
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
招募中1/2 期
- START Midwest, Grand Rapids
A Study of Lorigerlimab in Participants With Advanced Solid Tumors
招募中2 期
- START Midwest, Grand Rapids
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
招募中1/2 期
- START Midwest, Grand Rapids
其他城市的 子宫内膜癌试验
- Houston, TX68 项研究
- New York City, NY52 项研究
- Boston, MA50 项研究
- Arlington, VA39 项研究
- Nashville, TN38 项研究
- Los Angeles, CA34 项研究
- St. Louis, MO29 项研究
- Philadelphia, PA28 项研究
- San Antonio, TX27 项研究
- Columbus, OH25 项研究
- Chicago, IL25 项研究
- Oklahoma City, OK25 项研究
Grand Rapids的其他研究
- 非小细胞肺癌44 项研究
- 结直肠癌40 项研究
- 癌症（所有类型）28 项研究
- 乳腺癌26 项研究
- 卵巢癌24 项研究
- 转移性癌症22 项研究
- 前列腺癌19 项研究
- 胃癌18 项研究
- 胰腺癌18 项研究
- 黑色素瘤17 项研究
- 头颈鳞状细胞癌15 项研究
- 三阴性乳腺癌15 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。